Company Filing History:
Years Active: 2001
Title: Aby Buchbinder: Innovator in HIV Research
Introduction
Aby Buchbinder is a notable inventor based in Great Neck, NY (US). He has made significant contributions to the field of HIV research, particularly through his innovative work on human monoclonal antibodies. His research aims to enhance the prevention and treatment of HIV infection.
Latest Patents
Buchbinder holds a patent for "Human monoclonal antibodies to the CD4-binding domain of HIV, uses thereof and synergistic neutralization of HIV." This patent describes human monoclonal antibodies that are specific for the CD4-binding domain of HIV gp120. These antibodies are instrumental in neutralizing HIV and preventing infection. The patent also discusses synergistic mixtures of antibodies that target different epitopes of gp120, enhancing their effectiveness against various strains of HIV.
Career Highlights
Buchbinder's career is marked by his dedication to advancing HIV research. His work has led to the development of therapeutic strategies that utilize monoclonal antibodies to combat HIV. His innovative approaches have the potential to significantly impact the treatment landscape for individuals infected with HIV.
Collaborations
Buchbinder has collaborated with esteemed colleagues such as Susan Zolla-Pazner and Miroslaw K Gorny. These partnerships have fostered a collaborative environment that enhances the research and development of effective HIV treatments.
Conclusion
Aby Buchbinder's contributions to HIV research through his innovative patents and collaborations highlight his commitment to improving health outcomes for those affected by HIV. His work continues to pave the way for advancements in the field.